| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.039 | 0.6 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.6 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.039 | 0.6 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |